Standard dosing and microdosing both come with tradeoffs. Here is what the current research actually shows, so you can talk to your prescribing provider with real information, not social media claims.
Get Started See the comparison ↓GLP-1 receptor agonists, like semaglutide and tirzepatide, are FDA-approved for weight management and type 2 diabetes at specific, studied doses. "Microdosing" refers to using amounts below the approved starting dose, or spacing doses out further than the approved schedule. The idea has become popular as a way to potentially ease into treatment or reduce side effects.
This comparison is for educational purposes only. It does not constitute medical advice, and it is not a recommendation for either approach. Your prescribing provider determines what is appropriate for you based on your individual health history.
Talk to a licensed prescribing provider about what dosing approach fits your health history and goals, with GLP + Me education and support included.
Start The Process